Op-Eds

Op-Ed

Can We Please Get Serious About Patents and Drug Pricing?

Barney Cassidy January 6, 2022

Op-Ed

World leaders should acknowledge that IP protections facilitate vaccine access

Andrei Iancu December 24, 2021

Op-Ed

Why does the FDA want to stop improving medicines via patent ‘areas of concern’?

Andrei Iancu November 8, 2021

Op-Ed

Time to Fight Back Against Big Tech’s IP Assault

Paul R. Michel October 25, 2021

Op-Ed

Biden is trying to undermine America’s world-leading IP protections

Andrei Iancu August 11, 2021

Op-Ed

Federal Tech, Trade Bill Needs IP Owner Transparency Tweaks

David Kappos and Paul R. Michel June 30, 2021

Op-Ed

Waiving Covid-19 vaccine patents won’t get shots in arms faster. It slows down new vaccines.

David Kappos and Paul R. Michel May 25, 2021

Op-Ed

No evidence that patents slow access to vaccines

Andrei Iancu April 13, 2021

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

Op-Eds

Can We Please Get Serious About Patents and Drug Pricing?

World leaders should acknowledge that IP protections facilitate vaccine access

Why does the FDA want to stop improving medicines via patent ‘areas of concern’?

Time to Fight Back Against Big Tech’s IP Assault

Biden is trying to undermine America’s world-leading IP protections

Federal Tech, Trade Bill Needs IP Owner Transparency Tweaks

Waiving Covid-19 vaccine patents won’t get shots in arms faster. It slows down new vaccines.

No evidence that patents slow access to vaccines

Contact

Menu